Touch the screen or click to continue...
Checking your browser...
dayleaf.pages.dev

Adolfo garcia sastre biography sample

          García-Sastre is Professor in the Department of Microbiology and Director of the..

          Adolfo Garcia-Sastre, PhD, reflects on the thrill of discovery and the connection between butterfly-catching, his hobby, and pursuing the universal flu vaccine.

        1. Adolfo Garcia-Sastre, PhD, reflects on the thrill of discovery and the connection between butterfly-catching, his hobby, and pursuing the universal flu vaccine.
        2. He was among the first members of the Vaccine Study Section of the NIH. In addition, he is an editor for Journal of Experimental Medicine and.
        3. García-Sastre is Professor in the Department of Microbiology and Director of the.
        4. Adolfo García-Sastre is professor at the Departments of Microbiology and of Medicine, and Director of the Global Health and Emerging Pathogens Institute.
        5. The García-Sastre laboratory focuses on viral host-pathogen interactions, vaccines, anti-viral drug development and cancer viroimmunotherapy.

          6. Adolfo García-Sastre

          Spanish and American academic

          Adolfo García-Sastre,(born in Burgos, 10 October 1964) is a Spanish professor of Medicine and Microbiology and co-director of the Global Health & Emerging Pathogens Institute at the Icahn School of Medicine at Mount Sinai in New York City.

          His research into the biology of influenza viruses has been at the forefront of medical advances in epidemiology.[1]

          García-Sastre is the author of more than 700 publications.

          Biography

          Born in Burgos, Spain, García-Sastre earned his PhD at the University of Salamanca.[citation needed] His research interest has been focused on the molecular biology of influenza viruses and several other negative-strandRNA viruses.

          His contributions to his field have included the generation and evaluation of influenza virus vectors as potential vaccine candidates against infectious diseases, including malaria and AIDS, as well as the development (with Peter Palese) of the fir